Alterola Biotech, Inc.
ABTI
$0.0013
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.78M | -2.58M | -2.37M | -3.21M | -1.74M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.40K | 210.90K | 538.30K | 492.40K | 378.50K |
| Change in Net Operating Assets | 326.50K | 406.10K | 389.00K | 1.20M | 218.00K |
| Cash from Operations | -2.32M | -1.97M | -1.45M | -1.52M | -1.14M |
| Capital Expenditure | -- | 166.90K | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.00K | 0.00 | 0.00 | 18.10K | 35.00K |
| Cash from Investing | -95.00K | 166.90K | 0.00 | 18.10K | 35.00K |
| Total Debt Issued | 3.72M | 2.65M | 1.47M | 894.60K | 1.19M |
| Total Debt Repaid | -1.06M | 38.50K | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 759.70K | 759.70K | 759.50K | 765.70K | 50.30K |
| Repurchase of Common Stock | -544.70K | -759.50K | -759.50K | -214.80K | -214.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -157.10K | -260.00K | -- | -50.30K | -50.30K |
| Cash from Financing | 2.72M | 2.43M | 1.47M | 1.40M | 977.80K |
| Foreign Exchange rate Adjustments | -230.30K | 45.60K | -28.00K | 100.60K | 123.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | 73.70K | 677.80K | -6.10K | -10.10K | -5.90K |